Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.
Chung CH, Zhang Q, Hammond EM, Trotti AM 3rd, Wang H, Spencer S, Zhang HZ, Cooper J, Jordan R, Rotman MH, Ang KK. Chung CH, et al. Among authors: cooper j. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):331-8. doi: 10.1016/j.ijrobp.2010.05.024. Epub 2010 Aug 21. Int J Radiat Oncol Biol Phys. 2011. PMID: 20732768 Free PMC article. Clinical Trial.
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).
Chung CH, Dignam JJ, Hammond ME, Klimowicz AC, Petrillo SK, Magliocco A, Jordan R, Trotti A, Spencer S, Cooper JS, Le QT, Ang KK. Chung CH, et al. Among authors: cooper js. J Clin Oncol. 2011 Apr 1;29(10):1326-34. doi: 10.1200/JCO.2010.32.3295. Epub 2011 Feb 28. J Clin Oncol. 2011. PMID: 21357786 Free PMC article. Clinical Trial.
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.
Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Cooper JS, et al. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1198-205. doi: 10.1016/j.ijrobp.2012.05.008. Epub 2012 Jun 30. Int J Radiat Oncol Biol Phys. 2012. PMID: 22749632 Free PMC article. Clinical Trial.
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. Fu KK, et al. Among authors: cooper js. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):7-16. doi: 10.1016/s0360-3016(00)00663-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924966 Clinical Trial.
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ, et al. Lee DJ, et al. Among authors: cooper js. Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):567-76. doi: 10.1016/0360-3016(95)00150-W. Int J Radiat Oncol Biol Phys. 1995. PMID: 7790241 Free article. Clinical Trial.
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia LR, Rotman M, Ortiz H. Lee WR, et al. Among authors: cooper js. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1069-75. doi: 10.1016/s0360-3016(98)00348-4. Int J Radiat Oncol Biol Phys. 1998. PMID: 9869231 Free article. Clinical Trial.
7,700 results